Abstract
Objective: We determined the autoantibody profile in autoimmune thyroid diseases (AITD) and examined the distribution of thyroid-related autoantibodies in other autoimmune disorders. Methods: We tested sera from 234 patients with Graves’ disease (GD), 130 with Hashimoto’s thyroiditis (HT), 249 with other autoimmune diseases, and 50 healthy controls by enzyme-linked immunosorbent assay or radioimmunoassay. Results: Autoantibodies except TSH receptor antibody (Ab), anti-thyroglobulin (Tg) Ab and anti-thyroid peroxidase (TPO) Ab were not significantly prevalent in patients with AITD despite a significantly high elevation of thyroid-related Ab. Significant prevalence of autoantibodies related to AITD was observed in type 1 diabetes patients. Elevation of anti-Tg Ab was seen in patients with primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH), and anti-TPO Ab was elevated in patients with PBC. Although the prevalence of anti-acetyl-choline receptor Ab and systemic lupus erythematosus (SLE)-related Ab was significant in AIH, primary Sjögren’s syndrome (pSS)-related Ab were also found in both liver diseases. In myasthenia gravis (MG) patients, thyroid-related Ab and pSS-related Ab were detected in both MG groups, although SLE-related Ab were limited to the anti-muscle specific kinase Ab-positive MG patients. In patients with connective tissue diseases, anti-Tg Ab and anti-TPO Ab were significantly prevalent. Conclusion: Thyroid-related Ab were significantly elevated in all autoimmune diseases. Conversely, the elevations of Ab were not significant in the patients with AITD, suggesting a close relationship between AITD and other immune-mediated diseases.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ballotti S, Chiarelli F, de Martino M. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part I. Horm Res 2006, 66: 132–41.
Chow S, Rizzo C, Ravitskiy L, Sinha AA. The role of T cells in cutaneous autoimmune disease. Autoimmunity 2005, 38: 303–17.
Scofield RH. Autoimmune thyroid disease in systemic lupus erythematosus and Sjögren’s syndrome. Clin Exp Rheumatol 1996, 14: 321–30.
Kawasaki E, Eguchi K. Genetics of fulminant type 1 diabetes. Ann N Y Acad Sci 2006, 1079: 24–30.
Sanders J, Evans M, Premawardhana LD, et al. Human monoclonal thyroid stimulating autoantibody. Lancet 2003, 362: 126–8.
Kamijo K, Ishikawa K, Tanaka M. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 2005, 52: 525–9.
Beever K, Bradbury J, Phillips D, et al. Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 1989, 35: 1949–54.
The Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20: 1183–97.
Sera N, Kawakami A, Nakashima T, et al. Fas/FasL mediated apoptosis of thyrocytes in Graves’ disease. Clin Exp Immunol 2001, 124: 197–207.
Ohta M, Obayashi H, Takahashi K, et al. Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin-dependent diabetes mellitus. Clin Chem 1996, 42: 1975–8.
Masuda M, Powell M, Chen S, et al. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay. Clin Chim Acta 2000, 291: 53–66.
Kawasaki E, Abiru N, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995, 8: 633–43.
Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia 2006, 49: 828–36.
Kawasaki E, Eguchi K. Current aspects on the clinical immunology and genetics of autoimmune diabetes in Japan. Diabetes Res Clin Pract 2007, 77: S104–9.
Kawasaki E, Yu L, Gianani R, et al. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs. J Clin Endocrinol Metab 1997, 82: 375–80.
Samuelsson U, Ludvigsson J, Sundkvist G. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM. Diabetes Res Clin Pract. 1994, 26: 155–62.
Kawasaki E, Takino H, Yano M, et al. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. J Autoimmun 1994, 7: 791–802.
Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347: 151–6.
Kobayashi T, Tamemoto K, Nakanishi K, et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993, 16: 780–8.
Kawasaki E, Takino H, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994, 43: 80–6.
Goswami R, Marwaha RK, Goswami D, et al. Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab 2006, 91: 4256–9.
Prázný M, Skrha J, Límanová Z, et al. Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol Res 2005, 54: 41–8.
Youssef WI, Tavill AS. Connective tissue diseases and the liver. J Clin Gastroenterol 2002, 35: 345–9.
Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004, 99: 1510–6.
MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 1997, 41: 423–31.
Shiraishi H, Motomura M, Yoshimura T, et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 2005, 57: 289–93.
Marinó M, Ricciardi R, Pinchera A, et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab 1997, 82: 438–43.
Kiessling WR, Pflughaupt KW, Ricker K, Haubitz I, Mertens HG. Thyroid function and circulating antithyroid antibodies in myasthenia gravis. Neurology 1981, 31: 771–4.
Pyne D, Isenberg DA. Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 2002, 61: 70–2.
Magaro M, Zoli A, Altomonte L, et al. The association of silent thyroiditis with active systemic lupus erythematosus. Clin Exp Rheumatol 1992, 10: 67–70.
Kausman D, Isenberg DA. Thyroid autoimmunity in systemic lupus erythematosus: the clinical significance of a fluctuating course. Br J Rheumatol 1995, 34: 361–4.
Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren’s syndrome. Transl Res 2006, 148: 281–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamura, H., Usa, T., Motomura, M. et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J Endocrinol Invest 31, 861–865 (2008). https://doi.org/10.1007/BF03346432
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346432